Henk Verheul

PROF.DR., (Principal Investigator)

19992020

Research output per year

If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

A specific microRNA profile as predictive biomarker for systemic treatment in patients with metastatic colorectal cancer

Poel, D., Gootjes, E. C., Bakkerus, L., Trypsteen, W., Dekker, H., van der Vliet, H. J., van Grieken, N. C. T., Verhoef, C., Buffart, T. E. & Verheul, H. M. W., 2020, In : Cancer Medicine.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer

Barat, A., Smeets, D., Moran, B., Zhang, W., Cao, S., Das, S., Klinger, R., Betge, J., Murphy, V., Bacon, O., Kay, E. W., Van Grieken, N. C. T., Verheul, H. M. W., Gaiser, T., Schulte, N., Ebert, M. P., Fender, B., Hennessy, B. T., McNamara, D. A., O’Connor, D. & 10 others, Gallagher, W. M., Cremolini, C., Loupakis, F., Parikh, A., Mancao, C., Ylstra, B., Lambrechts, D., Lenz, H. J., Byrne, A. T. & Prehn, J. H. M., 1 Dec 2020, In : Scientific Reports. 10, 1, 9778.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Activities

  • 1 Oral presentation

Rapid development of peritoneal metastases after adjuvant chemotherapy is associated with worse survival after cytoreduction and HIPEC.

NR Sluiter (Speaker), Y Salhi (Speaker), G Kazemier (Speaker), HMW Verheul (Speaker), JB Tuynman (Speaker)
Sep 2017

Activity: Talk or presentationOral presentation